Aleksandra Rucka

Aleksandra Rucka

Auto-generated profile, based on publicly available information

Aleksandra Rucka

Medical University of Lublin

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
NCNikodem Cieleban
Nikodem Cieleban
MRMichał Rucki
Michał Rucki
ARAleksandra Rucka
Aleksandra Rucka
Background. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have evolved from their origins as antihyperglycemic agents to become a cornerstone of cardiorenal therapy. The high prevalence of coexisting heart failure (HF) and chronic kidney disease (CKD) creates a complex clinical syndrome where traditional glucose-centric management is insufficient. Aim. To provide an exhaustive narrative scientific review of the clinical, molecular, and guideline-driven evidence for SGLT2 inhibitors in patients with concurrent heart failure and chronic kidney disease, emphasizing outcomes that transcend glycemic control. Material and methods. A narrative literature review was conducted using PubMed/MEDLINE, Embase, and the Cochrane Library for articles published between January 2015 and January 2026. Keywords included "SGLT2 inhibitors", "heart failure", "chronic kidney disease", "eGFR", "albuminuria", and "cardiorenal syndrome". Results. Large-scale randomized controlled trials (DAPA-HF, EMPEROR-Reduced, DAPA-CKD, and EMPA-KIDNEY) and recent meta-analyses like SMART-C (2025) demonstrate that SGLT2 inhibitors reduce cardiovascular death and heart failure hospitalizations by approximately 25%, while slowing renal progression by 30-40% across various eGFR and albuminuria strata. These benefits are mediated through the restoration of tubuloglomerular feedback, metabolic switching toward oxygen-efficient ketone bodies, and direct anti-inflammatory pathways. Conclusions. SGLT2 inhibitors are foundational therapies for the cardiorenal axis. Their use is now recommended down to an eGFR of 20 mL/min/1.73 m², with benefits extending into advanced CKD stages. Clinicians must integrate these agents early in the disease course to maximize organ preservation and survival.

10 June 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
MMMagdalena Modliborska
Magdalena Modliborska
MRMichał Rucki
Michał Rucki
NCNikodem Cieleban
Nikodem Cieleban
ARAleksandra Rucka
Aleksandra Rucka
MKMateusz Kowalski
Mateusz Kowalski
MGMaja Gajewska
Maja Gajewska
Background: Electronic cigarettes (e-cigarettes) are now the most widely used inhalational nicotine product among adolescents and young adults. Although marketed as safer than combustible tobacco, accumulating evidence indicates that vaping injures the vascular endothelium and elevates cardiovascular disease (CVD) risk. Aim: This review synthesizes current evidence on how e-cigarette aerosol affects endothelial function and the resulting cardiovascular consequences, with attention to mechanism, population outcomes, and special populations. Material and methods: PubMed, MEDLINE, Google Scholar, JEHS, and Quality in Sport were searched for peer-reviewed publications between 2015 and 2026, combining "e-cigarette" or "vaping" with terms for endothelial function, flow-mediated dilation, and cardiovascular outcomes. Results: E-cigarette aerosol carries nicotine, propylene glycol and vegetable glycerin thermolysis products, flavorings, and metals leached from heating coils. Acute use raises pulse-wave velocity by approximately 0.26 m/s and heart rate by about 5 beats/min. Chronic users show flow-mediated dilation reduced to roughly 5% versus 11% in non-users. Mechanisms include eNOS uncoupling, NADPH-oxidase activation, formaldehyde-driven TRPA1 signaling, flavoring-induced inflammation, and increased platelet reactivity. Daily vaping was associated with self-reported myocardial infarction in NHIS data (OR 1.79, 95% CI 1.20–2.66); dual use carried higher CVD odds than exclusive smoking (OR 2.56, 95% CI 2.11–3.11). Conclusions: E-cigarettes are not cardiovascularly neutral. They impair endothelial function through multiple, partially nicotine-independent pathways and are associated with adverse cardiovascular outcomes, particularly in dual users and youth.

16 April 2026 in Quality in Sport
Verified
Journal Article
Open access
ARAleksandra Rucka
Aleksandra Rucka
MRMichał Rucki
Michał Rucki
NCNikodem Cieleban
Nikodem Cieleban
MMMagdalena Modliborska
Magdalena Modliborska
MKMateusz Kowalski
Mateusz Kowalski
Background: Obesity has evolved from a simple metabolic condition into a complex, chronic systemic disease that has reached pandemic proportions in the 21st century. It serves as a primary driver for a multitude of chronic pathologies across virtually every human organ system. Aim: This narrative review aims to provide a comprehensive analysis of the major groups of obesity complications, exploring their pathophysiological mechanisms and epidemiological impact across the lifespan, with a focus on pediatric development and geriatric well-being. Material and methods: A systematic search of PubMed, MEDLINE, Google Scholar. Selection criteria prioritized peer-reviewed articles, meta-analyses, and cohort studies published between 2014 and 2026, focusing on the mechanisms of metabolic, cardiovascular, respiratory, musculoskeletal, and psychosocial impairment. Results: Metabolic complications of obesity include type 2 diabetes and hyperuricemia, while cardiovascular effects range from hypertension to coronary artery disease. Respiratory health is compromised by mechanical and inflammatory pathways, leading to obstructive sleep apnea and hypoventilation. Pediatric studies demonstrate that excessive weight significantly accelerates skeletal and dental maturation, while geriatric data highlight severe declines in self-esteem and social integration. Conclusions: The complications of obesity are intrinsically linked to chronic low-grade inflammation and hormonal dysregulation. Management must move beyond simple weight loss to address the systemic inflammatory environment and the varied psychosocial consequences.

8 May 2026 in Quality in Sport
Verified
Journal Article
Open access
MKMateusz Kowalski
Mateusz Kowalski
MRMichał Rucki
Michał Rucki
NCNikodem Cieleban
Nikodem Cieleban
ARAleksandra Maria Rucka
Aleksandra Maria Rucka
MMMagdalena Modliborska
Magdalena Modliborska
Background. Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) are foundational pharmacological therapies for hypertension and cardiovascular diseases. However, their potential interference with physiological adaptations to endurance training, particularly maximal aerobic capacity (VO2 max), remains a critical concern for clinicians and athletes. Aim. This review aims to synthesize the current evidence regarding the impact of ACEi and ARB therapy on VO2 max, hematological parameters, and cardiac remodeling in patients and healthy individuals undergoing structured endurance training. Material and methods. A narrative review was conducted using PubMed, Google Scholar, and the archives of the Journal of Education, Health and Sport and Quality in Sport. Search terms included "ACE inhibitors," "angiotensin receptor blockers," "VO2 max," and "endurance training." Inclusion criteria focused on peer-reviewed articles published between 2015 and 2025, emphasizing human clinical trials and systematic reviews. Results. Evidence suggests that while chronic RAAS inhibition does not significantly attenuate relative VO2 max gains in hypertensive populations or those with metabolic syndrome, it may compromise specific physiological determinants. Notably, ACEi treatment has been associated with a reduction in total hemoglobin mass expansion and a blunting of lean mass accrual. Furthermore, sex-specific responses indicate that women may experience a more pronounced inhibition of aerobic adaptations compared to men when using standard ARB dosages. Conclusions. ACEi and ARBs are generally compatible with aerobic exercise; however, their impact on hematological and morphological adaptations requires careful consideration, especially in high-performance or female cohorts. Exercise remains a vital synergistic co-therapy for managing hypertension alongside these medications.

13 July 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
ARAleksandra Rucka
Aleksandra Rucka
MKMateusz Kowalski
Mateusz Kowalski
MRMichał Rucki
Michał Rucki
NCNikodem Cieleban
Nikodem Cieleban
MGMaja Gajewska
Maja Gajewska
MMMagdalena Modliborska
Magdalena Modliborska
Background. Alzheimer's disease (AD) accounts for 60–70% of the over 57 million dementia cases worldwide and is projected to nearly triple by 2050. Neuropathology precedes symptoms by roughly two decades, and the approval of anti-amyloid therapies has made biomarker-confirmed early diagnosis a clinical priority. Aim. This narrative review synthesizes evidence on cerebrospinal fluid (CSF), blood, neuroimaging, genetic, retinal, and emerging molecular biomarkers for early detection of AD, framed within the 2024 revised NIA-AA biological criteria. Material and methods. PubMed, MEDLINE, Google Scholar, the Journal of Education, Health and Sport, and Quality in Sport were searched for studies and consensus documents published between 2014 and 2026. Six mandatory references were integrated with seventeen additional peer-reviewed sources. Results. CSF Aβ42/40, total tau, and p-tau181 remain reference-standard markers. Plasma p-tau217 has emerged as the leading minimally invasive biomarker, with areas under the curve of 0.92–0.96 against amyloid PET. Serum neurofilament light and glial fibrillary acidic protein support staging and differential diagnosis. Amyloid and tau PET enable in vivo Braak staging; structural MRI tracks hippocampal atrophy. APOE ε4 genotyping has regained clinical relevance in the anti-amyloid era. Optical coherence tomography, metabolomics, microRNAs, and AI-driven multimodal models expand the diagnostic frontier. Conclusions. AD can now be detected biologically before symptoms become disabling. Translating plasma assays and AI-supported imaging into routine practice is the central challenge of the coming decade.

12 June 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MRMichał Rucki
Michał Rucki
NCNikodem Cieleban
Nikodem Cieleban
ARAleksandra Rucka
Aleksandra Rucka
MMMagdalena Modliborska
Magdalena Modliborska
MKMateusz Kowalski
Mateusz Kowalski
MGMaja Gajewska
Maja Gajewska
Background: Social media use is near-universal among adolescents and young adults, with up to 95% of those aged 13–17 reporting active use and more than one third using it "almost constantly." Anxiety and depression indicators have risen sharply in this age band since the early 2010s, raising concern about a causal contribution. Aim: This narrative review synthesizes correlational, longitudinal, and experimental evidence linking social media overuse to anxiety and depression, with attention to mediators, vulnerable populations, and intervention efficacy. Material and methods: PubMed, MEDLINE, Google Scholar, the Journal of Education, Health and Sport (JEHS), and Quality in Sport (QS) were searched for peer-reviewed publications from 2014 to 2026, supplemented by World Health Organization and U.S. Surgeon General reports. Inclusion was restricted to original research, meta-analyses, systematic reviews, and randomized trials. Results: Pooled estimates indicate that depression risk rises by 13% per additional hour of daily use, and adolescents using platforms more than three hours daily approximately double their risk of poor mental health outcomes. Effects are larger in girls than boys and are mediated principally by sleep displacement, upward social comparison, fear of missing out, and cyberbullying. Randomized trials show that limiting use to roughly 30 minutes daily, or abstaining for one week, produces measurable reductions in depressive and anxious symptoms. Critical reanalyses caution that aggregate effect sizes are small in absolute terms, with platform use explaining roughly 0.4% of adolescent well-being variance. Conclusions: Social media overuse is consistently associated with higher anxiety and depression risk, with the strongest signal in adolescent girls and in patterns marked by passive nighttime browsing. Time-limiting and abstinence interventions are promising and warrant integration into preventive mental-health care.